IP Library Granted Patent US 6,977,178
Granted Patent B2
US 6,977,178 · App. 10/233,942 · Granted Dec 20, 2005

System and method for transgenic and targeted mutagenesis screening

Assignee: TransnetYX, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,977,178
App. No.
10/233,942
Granted
Dec 20, 2005
Kind
B2
Abstract

The present invention provides a method and apparatus for to conduct transgenic and targeted mutagenesis screening of genomic DNA. This invention also provides a system for screening DNA for a designated genetic sequence. The system includes a computer having a processor, memory and web browser, wherein the computer receives instructions concerning the designated genetic sequence and other screening parameter selection from a remote user via a form of electronic communication, and an automatic screening device that analyzes samples of genomic DNA for the designated sequence.

Claims (8)

1. In a method for detecting a designated genetic sequence in a sample of murine genomic DNA, obtained from a lysed tissue sample, in a solid phase hybridization assay including a bipartite probe specific for a portion of said murine genomic DNA, the improvement comprising:

separating said murine genomic DNA from said lysed tissue sample using magnetic particles and immobilizing said murine genomic DNA on to a solid phase, wherein said bipartite probe has a first region specific for a portion of said murine genomic DNA and a second region that binds to a signal emitting dendrimer.

2. The method of claim 1 wherein said signal emitting dendrimer is cyanine 3.

3. The method of claim 1 wherein said probe specific for a portion of said murine genonlic DNA is selected from the group consisting of: SEQ ID NO. 19, SEQ ID NO. 20, SEQ ID NO. 21, SEQ ID NO. 22, SEQ ID NO. 23, SEQ ID NO. 24, and SEQ ID NO. 25.

4. The method of claim 1 wherein said murine genomic DNA concentration is about 12.5 to 500 ng/μL.

5. The method of claim 1 wherein the murine genomic DNA concentration is 17 ng to 250 ng/μL.

6. The method of claim 1 wherein said solid phase is an optically flat substrate.

7. The method of claim 6 wherein said optically flat substrate is glass.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Apr 10, 2018
From: LANDMARK COMMUNITY BANK
To: TRANSNETYX, INC.
Reel/Frame 045496/0474 →
RELEASE OF SECURITY INTEREST Recorded Apr 10, 2018
From: PENINSULA FUND V LIMITED PARTNERSHIP
To: TRANSNETYX, INC.
Reel/Frame 045496/0775 →
SECURITY INTEREST Recorded Apr 30, 2015
From: TRANSNETYX, INC.
To: THE PENINSULA FUND V LIMITED PARTNERSHIP
Reel/Frame 035539/0054 →
SECURITY INTEREST Recorded May 29, 2014
From: TRANSNETYX
To: LANDMARK COMMUNITY BANK
Reel/Frame 033053/0834 →
JOINT RESEARCH AND DEVELOPMENT AGREEMENT Recorded Nov 17, 2005
From: O'MALLEY, SHAWN
To: TRANSNETYX, INC.
Reel/Frame 016794/0057 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2002
From: HODGE, TIMOTHY A.
To: TRANSNETTYX, INC.
Reel/Frame 013133/0455 →
Continuity (3)
Continuation 0994595200 · Sep 4, 2001
Provisional Application 6023037100 · Sep 6, 2000
Related Publication 20030165922A1 · Sep 4, 2003